Search this website:

Official ICSE & CPHI supporting publication

A quick solution

Fast melt technology allows tablets to be taken any time, anywhere, without water. The development and commercial manufacture of fast melt, orodispersible tablets (ODT), along with effervescent technology, are at the forefront of focus for Swiss drug delivery company Alpex Pharma.

Capabilities include:

  • Orodispersible tablets (fast melt technology)
  • Effervescent technology
  • Formulation development and consequent commercial manufacturing
  • Contract manufacturing in GMP state-of-the-art facility
  • Taste masking

Advantages of Alpex ODT:

  • Convenient dosage form at any time and place, can be taken without water
  • Easy to use for patients with swallowing disorder
  • Potential faster onset of action than conventional oral dosage forms
  • Increased patient compliance
  • Broad applicability to many therapeutic categories
  • Lifecycle management, expanded patent protection
  • High drug concentration, up to 500mg/tablet
  • Marketing advantage – greater choice

for patients and consumers Alpex Pharma employs a unique patent protected process for the manufacturing of ODT tablets. Its tablets have a significant advantage, as they are robust enough to be filled into bottles and shipped in bulk and do not have strict restrictions for drug loading or use of tastemasking technologies.

ODT technology can be applied across many categories: analgesics/inflammation, Parkinson's, migraine, hypnotics/narcotics, antacids/ulcer, erectile dysfunction, antidiarrhoeas, cough/cold/flu remedies, antiemetics, cardiovascular, antihistamines, irritable bowel.

Company profile

Alpex pharma

For further information, visit: www.alpex.com

Email: contact@alpex.com

Tel: +41 935 51 10
Fax: +41 91 935 51 20

If you require more information on this company or its products then click here